secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001326110-23-000014
Event type: litigation
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio obtains $176.4M judgment against Sorrento confirmed by court; $159.4M payable to subsidiary
--------------------------------------------------------------------------------

- LA County Superior Court confirms $176.37M arbitration award against Sorrento; $159.42M payable to ImmunityBio subsidiary NantCell.
- Court grants injunction barring Sorrento from overseas transfers >$1M and insider transfers until award is paid.
- Judgment includes 10% post-judgment interest; arbitrator previously awarded $173.5M with prejudgment interest.
- ImmunityBio intends to pursue collection vigorously but provides no assurance on full recovery or timing.
- Other disputes between ImmunityBio affiliates and Sorrento remain pending; Company will defend claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000132611023000014/0001326110-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000132611023000014/ibrx-20230207.htm
  HTML page:      https://secwatch.observer/filing/0001326110-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer